For years, prior authorization has been a defining feature of Medicare Advantage and commercial health plans. Traditional Medicare, however, has largely avoided it — until now. Beginning Jan. 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch one of its most significant oversight experiments yet: the Wasteful and Inappropriate Services Reduction (WISeR) Model.
The initiative introduces prior authorization into fee-for-service Medicare for a select but impactful set of “high-risk” services. For providers, the shift represents more than a policy update — it marks a meaningful change in daily workflow, documentation expectations and operational readiness. With less than a year until implementation, the question becomes: What will WISeR mean for your practice, and how can you prepare?
What Is the WISeR Model?
The WISeR Model is a six-year demonstration project aimed at reducing inappropriate care and preventing improper payments under Medicare Part B. CMS describes the model as a way to curb wasteful services while ensuring beneficiaries receive medically necessary care.
To do this, the WISeR model introduces a layered review process. Claims for selected services will require prior authorization. Requests will go through an initial AI- or algorithm-supported triage but must receive a final human clinical review before a denial is issued. This hybrid review process is designed to make oversight both efficient and consistent, though many provider groups have raised concerns about accuracy, turnaround time and burden.
WISeR will initially operate only in certain states, but CMS has indicated that findings could influence national policy. That possibility alone has many organizations preparing early.
What Services Will Be Affected?
The WISeR model focuses on services CMS deems “high-risk” for overuse, questionable medical necessity or improper documentation. The initial list includes:
- Skin and tissue substitutes for chronic wounds
- Electrical nerve stimulation devices
- Pain management procedures
- Orthopedic services, such as knee arthroscopy
- Select surgical procedures that have historically shown inconsistent utilization patterns
What lands these services on CMS’s high-risk list is not necessarily fraud but variation — especially when documentation, conservative therapy history or diagnostic evidence is incomplete. Under WISeR, these gaps may result in delayed approvals or outright denials.
How the New Prior-Authorization Process Works
Beginning in 2026, providers in participating states will need prior authorization before performing any WISeR-listed service. Claims submitted without approval may undergo pre-payment review or face denial.
The process works in three steps:
- Submission: Providers send detailed clinical documentation, including history, exam findings, treatment course, imaging or diagnostics, and justification for the requested service.
- AI-supported triage: Technology helps categorize or route requests, but does not finalize clinical decisions.
- Human review: A licensed clinician must review cases before a denial is issued. CMS specifies that vendors cannot tie compensation to denial volume.
Despite those safeguards, the burden still falls heavily on providers. Practices must ensure every request includes complete, accurate and well-organized documentation — something many workflows are not currently designed to handle.
Why CMS Is Doing This
CMS cites several motivations:
- Reducing improper payments: Billions are paid each year for services that are incorrectly coded, insufficiently documented or medically unnecessary.
- Aligning oversight across Medicare: Traditional Medicare has fewer controls than Medicare Advantage, where prior authorization has long been standard.
- Testing new review models: CMS wants to evaluate whether AI-assisted processes can improve consistency and reduce administrative friction over time.
While CMS frames the WISeR Model as a modernization effort, many providers view it as additional complexity at a time when administrative load is already at historic highs.
Challenges Providers May Face
Provider organizations have raised several concerns since the model was announced:
- Care delays: Prior authorization has a well-documented track record of postponing or obstructing timely care.
- Increased documentation pressure: Subspecialties like wound care and pain management may feel this most acutely.
- Workflow disruption: Clinical and administrative teams must adapt quickly to new processes and approval timelines.
- Uncertainty around appeals: Consistency and clarity in appeals under a new AI-plus-human model remain unknown.
- Potential model expansion: If CMS sees value in WISeR, it could broaden the list of services or expand the program nationally.
The takeaway: Providers that rely on manual, fragmented workflows may struggle to keep pace with new requirements.
How Providers Can Prepare — and How Pre-Visit Assurance Helps
Preparation should begin well before the Jan. 1, 2026 go-live date. Key steps include:
- Inventory at-risk services: Identify which procedures your organization performs that fall under WISeR.
- Standardize documentation: Ensure templates prompt for all clinical elements CMS expects — history, diagnostic evidence, conservative therapy steps and more.
- Train teams early: Billing, coding, intake and clinical staff all play a role in prior authorization readiness.
- Audit recent claims: Look for past denials that may signal gaps in documentation or coding.
- Centralize prior auth workflows: Consolidated processes reduce errors and accelerate approvals.
This is also where HealthCell’s Pre-Visit Assurance can support providers. The service reviews documentation requirements, verifies insurance benefits, confirms prior-authorization needs and identifies gaps before the patient encounter. By resolving issues up front, practices can reduce administrative delays, ensure compliant submissions and protect revenue — all critical advantages under a heightened oversight model like WISeR.
What to Watch in 2026 and Beyond
While WISeR model begins as a pilot, it has the potential to reshape Medicare oversight long term. Providers should monitor:
- State-level expansion or national rollout
- Changes to the list of high-risk services
- Policy updates driven by provider feedback or patient access concerns
- Turnaround times for approvals and appeals
- How effectively AI-supported review performs
As prior authorization becomes a more front-loaded process, many organizations may seek operational partners to manage rising complexity. Pre-visit services like those offered by HealthCell are positioned to become increasingly valuable in a regulatory environment that rewards advance preparation and complete documentation.
Conclusion
The WISeR Model marks a significant shift for traditional Medicare, bringing prior authorization into areas where providers have long operated without it. For affected specialties, the impact will be immediate: more documentation, new workflows and greater scrutiny of claims.
Practices that prepare now will be strongest in 2026. By tightening internal processes, training teams and reinforcing documentation standards, providers can reduce the risk of delays and denials.
And with services such as HealthCell’s Pre-Visit Assurance, organizations can go a step further — proactively ensuring that documentation, eligibility and authorization requirements are met before the patient ever arrives. It’s a strategic way to stay compliant, protect revenue and keep patients at the center of care as Medicare oversight evolves.
